About the role
About Apheris Apheris powers federated life sciences data networks, addressing the critical challenge of accessing proprietary data locked in silos due to IP and privacy concerns. We enable leading pharmaceutical teams to discover and develop drugs faster. We host the industry’s largest federated data networks for drug discovery AI, spanning co-folding, ADMET, and antibody develop ability. Across these networks, models are trained on proprietary industry datasets to achieve higher performance and broader applicability while keeping data control and IP protected. We deliver these superior models through drug discovery applications that enable teams to run them at scale, further customize them, and integrate them into existing R&D workflows. AI Structural Biology (AISB) Network: Pharmaceutical companies collaborate in the field of co-folding, structure-based binding affinity predictions and antibody design. ADMET Network: Pharmaceutical and biotech companies collaborate to improve small-molecule property prediction and expand into further drug modalities. Antibody Develop ability Network: Pharma partners collaborate to federate historical and purpose-built antibody develop ability data sets for secure ML training, without data leaving each partner’s environment.
About
the role At Apheris, we power federated data network in life sciences to address the data bottleneck in training highly performant ML models. Publicly available, molecular datasets are insufficient to train high-quality ML models that meet industry
requirements. Our product addresses this by hosting networks where biopharma organizations collaboratively train higher quality models on their combined data. The Apheris product is a set of drug discovery applications - enriched with the proprietary data of network participants. Our federated computing infrastructure with built-in governance and privacy controls ensure that the data IP and ownership always stays with the data custodians. As we are doubling down on structural biology use cases as a focus area within our drug discovery work, we are looking for a Senior ML Engineer to drive the technical execution for our structural biology models. This is a hands-on, high-impact role focused on advancing the state of the art in applying foundational models to structural biology problems. You’ll work closely with our leadership team and will serve as the technical authority on ML modelling, architecture, and experimentation in this domain. You should bring deep expertise in training and deploying contemporary models for protein structure prediction and related tasks. You must also understand the application of these models in drug discovery workflows and have a track record of setting strategy, breaking down complex technical problems, and delivering impactful ML systems. If you want to be part of a mission-driven team building cutting-edge AI systems for life sciences – and you know what it takes to move from foundational models to domain-specific impact – this role is for you. About you What you will do Build and implement ML applications in structural biology, particularly around fine-tuning and extending foundational models like OpenFold, Boltz-2 and ESMFold. Design and implement model extensions for specific tasks such as protein complex and binding affinity prediction, including data distillation, benchmarking, and evaluation pipelines. Work with our customers and academic partners to define data preprocessing, selection, and benchmarking strategies for novel training tasks involving protein structures, complexes, and multimodal biological data. Carry out case-studies associated with the above, providing scientific and technical expertise to our customers. You will be involved in the full project pipeline, from scoping through to results delivery and dissemination. Design, build, and maintain scalable machine learning models and the pipelines needed for training, inference, and deployment in production. Collaborate cross-functionally to ensure models address real-world drug discovery needs. Contribute to publications or open-source contributions where relevant. What we expect from you By month 3: Develop a deep technical understanding of the Apheris product and how it maps to the current Structural Biology use-cases we are working on. Contribute to delivery of at least one customer-driven cofolding project. By month 6: Building on the outcomes of the aforementioned project, build a customer-ready package for results analysis. Work with our privacy team to understand potential for model reverse-engineering. Drive adoption of the Apheris-generated models with our customers for real-world drug discovery pipelines. By month 12: Take ownership of a customer-driven cofolding model development stream, drive product